AMENDMENT NO. 2 TO HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENTAlbumin Ingredient Purchase and Sale Agreement • October 20th, 2015 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2015 Company Industry JurisdictionThis Amendment (this “Amendment”) No. 2 to the Human Serum Albumin Ingredient Purchase and Sale Agreement is made and entered into as of October 8, 2015 by and between Octapharma USA, Inc., a Virginia corporation (“Supplier”), and Ampio Pharmaceuticals, Inc., a Delaware corporation (“Customer”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Agreement (as defined below).